Page last updated: 2024-09-05

avasimibe and Hyperlipemia

avasimibe has been researched along with Hyperlipemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Voogd, NJ; Eguchi, K; Fujiwara, Y; Hayashida, A; Horlad, H; Kato, H; Losung, F; Mangindaan, RE; Rotinsulu, H; Takeya, M; Tsukamoto, S1
Burnett, JR; Huff, MW1
Alegret, M; Laguna, JC; Llaverías, G1
Badimon, JJ; Chew, DP; Corti, R; Fallon, JT; Fayad, ZA; Fuster, V; Helft, G; Worthley, MI; Worthley, SG; Zaman, AG1

Reviews

3 review(s) available for avasimibe and Hyperlipemia

ArticleYear
Avasimibe Pfizer.
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:9

    Topics: Acetamides; Acetates; Animals; Arteriosclerosis; Clinical Trials as Topic; Drug Industry; Enzyme Inhibitors; Humans; Hyperlipidemias; Sulfonamides; Sulfonic Acids

2002
Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
    Cardiovascular drug reviews, 2003,Spring, Volume: 21, Issue:1

    Topics: Acetamides; Acetates; Animals; Anticholesteremic Agents; Clinical Trials as Topic; Enzyme Inhibitors; Humans; Hyperlipidemias; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids

2003
Avasimibe. CI 1011.
    Drugs in R&D, 2002, Volume: 3, Issue:3

    Topics: Acetamides; Acetates; Animals; Clinical Trials as Topic; Drug Industry; Humans; Hyperlipidemias; Sulfonamides; Sulfonic Acids

2002

Other Studies

2 other study(ies) available for avasimibe and Hyperlipemia

ArticleYear
Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo.
    Bioorganic & medicinal chemistry, 2013, Jul-01, Volume: 21, Issue:13

    Topics: Alkaloids; Animals; Atherosclerosis; Carbazoles; Cells, Cultured; CHO Cells; Cholesterol; Cholesterol Esters; Cricetinae; Cricetulus; Foam Cells; Humans; Hyperlipidemias; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Porifera; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2

2013
Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Pathophysiology of haemostasis and thrombosis, 2007, Volume: 36, Issue:1

    Topics: Acetamides; Acetates; Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Magnetic Resonance Imaging; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Pyrroles; Rabbits; Random Allocation; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids

2007